• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Model Number S-55-150-120-P6
Device Problems Improper or Incorrect Procedure or Method (2017); Difficult or Delayed Activation (2577); Material Deformation (2976)
Patient Problems Ischemia (1942); Stenosis (2263)
Event Date 03/17/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.Reportedly, during deployment the thumbslide was not advanced to the most distal position.It should be noted that the supera instruction for use (ifu) states: under fluoroscopy, slowly rotate the thumb slide to the most distal position on the handle.It is undetermined if the deviation of the ifu caused/contributed to the difficulties.It is possible that during deployment interaction with the severely calcified anatomy in conjunction with failing to advance the thumb slide to the most distal position resulted in the reported difficulty to deploy and the reported material deformation/ stent invagination; however this cannot be confirmed.The investigation determined a conclusive cause for the reported difficulties cannot be determined.The reported difficulties possibly contributed to the reported patient effects however a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.Literature attachment.Article title ¿invagination and restenosis of an interwoven nitinol stent multiple imaging modality findings.¿.
 
Event Description
It was reported that the procedure on (b)(6) 2020 was to treat an ulcer in a severely calcified right femoropopliteal artery.After pre-dilatation with a 5x80mm non-abbott balloon (18atmospheres (atm), 2minutes (min), 3 times), a 5.5x150mm supera stent was to be implanted.The deployment lock was unlocked and the stent was released, but the thumbslide wasn't advanced to the most distal position during deployment.At the mid-portion of the stent, stent invagination occurred during deployment.The stent was ultimately implanted.After high-pressure balloon dilatation (28 atm, 3 min, twice, 6×40mm non-abbott balloon), final angiography revealed acceptable blood flow to below the knee, but stent invagination was unchanged.Two months later, the patient's ulcer healed completely.However, at 6 months (b)(6) 2020, the patient was symptomatic with the recurrence of the ulcer and critical right limb ischemia.Angiography confirmed 90% restenosis at the mid-portion of the stent, corresponding to the stent invagination.Via intravascular imaging it was noted that the struts had a ¿spider¿s web¿ appearance at the stent invagination and were almost totally covered with large amounts of neointima, leading to lumen loss.Balloon angioplasty with a 6x100mm non-abbott balloon was performed to treat the restenosis.On 4/20/21, fluoroscopy was performed and showed no restenosis present.No additional information was provided.Details are listed in the attached article, titled "invagination and restenosis of an interwoven nitinol stent multiple imaging modality findings.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key12294587
MDR Text Key265608274
Report Number2024168-2021-06955
Device Sequence Number1
Product Code NIP
UDI-Device Identifier08717648226168
UDI-Public08717648226168
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 08/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/09/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2021
Device Model NumberS-55-150-120-P6
Device Catalogue NumberS-55-150-120-P6
Device Lot Number9030561
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/27/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/05/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PARENT SHEATH,6.0FR,48CM
Patient Outcome(s) Required Intervention;
Patient Age72 YR
Patient Weight56
-
-